BPA Call 36C24820A0028-36C24822N0055
- Biofire Diagnostics LLC received a $1.27 million firm fixed-price BPA call award from the Department of Veterans Affairs' Veterans Integrated Service Network 8 for molecular pathogen detection services. The contract was awarded on November 29, 2023, with an ultimate completion date of September 30, 2024, and will be performed in Emigration Canyon, Utah. This award represents a task order against Biofire's existing General Services Administration Federal Supply Schedule contract (FSS-65-VII)...
- Biofire Diagnostics, LLC was awarded a $129,420 firm fixed price blanket purchase agreement (BPA) call contract by the Department of Veterans Affairs Veterans Health Administration (VA/VHA) Veterans Integrated Service Network 23 (VISN 23). The contract is for virus, bacteria, and parasite detection systems to support VISN 23's clinical diagnostic testing programs. Biofire will provide its FilmArray system and associated consumables to several VA medical centers in Utah under the agreement. No...
- Biofire Diagnostics LLC was awarded a blanket purchase agreement (BPA) call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17. The contract has a potential value of $156,971.13 to provide laboratory supplies for use with Biofire's proprietary equipment through July 25, 2023. No set-aside designation was used. The award was issued against Biofire's General Services Administration Federal Supply Schedule contract for in vitro...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a Blanket Purchase Agreement (BPA) call order to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $146,700 contract is for the provision of virus, bacteria, and parasite detection systems, including molecular diagnostic testing services and products, COVID-19 testing reagents and equipment, and maintenance services for Biofire systems. This award was made...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The award, valued at $1,598,542.00, is for molecular pathogen detection products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration...
- This contract was awarded by the Department of Veterans Affairs Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company specializing in infectious disease testing. The contract is a Blanket Purchase Agreement (BPA) call valued at $278,640.00 for the provision of virus, bacteria, and parasite detection systems. The contract is part of a larger BPA established under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics,...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract, valued at $810,091.80, was awarded by the Veterans Health Administration (VHA) of the Department of Veterans Affairs (VA) under the VA's Veterans Integrated Service Network (VISN) 8. The contract is a BPA (Blanket Purchase Agreement) call against Biofire's General Services Administration (GSA) Federal Supply...
- This is a federal contract award to Biofire Diagnostics LLC, a biotechnology company that specializes in syndromic infectious disease testing. The contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), is for molecular pathogen detection services. The contract has a ceiling value of $513,156.00 and a period of performance through September 30, 2024. The contract was awarded against Biofire's existing General Services Administration (GSA) Federal...
- Biofire Diagnostics LLC received a $612,895.93 firm fixed-price blanket purchase agreement (BPA) call from the Department of Veterans Affairs' Veterans Integrated Service Network 12 on September 28, 2023, for multiplex PCR pathogen reagent (CPRR) products. The contract extends through November 20, 2025, and is performed at the contractor's facility in Emigration Canyon, Utah. This award was issued without a set-aside designation and falls under the company's existing GSA Federal Supply...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a Blanket Purchase Agreement (BPA) call to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $30,360.00 contract provides virus, bacteria, and parasite detection systems and is funded through VHA's Veterans Integrated Service Network (VISN) 23. Biofire Diagnostics holds a General Services Administration (GSA) Federal Supply Schedule contract for in-vitro...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797D30085-36C24820A0028Blanket Purchase Agreement
- 36C24820A0028-36C24822N0055BPA Call
Biofire Diagnostics LLC, a Salt Lake City-based biotechnology company, received a $1.51 million firm fixed-price blanket purchase agreement (BPA) call from the Department of Veterans Affairs' Veterans Integrated Service Network 8 for molecular pathogen detection capabilities. The contract, awarded on October 1, 2021, with an ultimate completion date of September 30, 2022, represents a delivery order against Biofire's existing General Services Administration Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests (FSS-65-VII). This award supports the VA's diagnostic testing infrastructure by providing Biofire's specialized molecular detection solutions, likely including reagents and FilmArray diagnostic systems that enable rapid identification of multiple pathogens from clinical samples. No set-aside designation was applied to this competitive procurement. This BPA call reflects Biofire Diagnostics' established position as a key federal healthcare supplier, with the company holding multiple significant contract vehicles across the VA system and other federal agencies. The award falls within the company's broader portfolio of firm fixed-price purchase orders and BPA calls that collectively support infectious disease diagnostic capabilities across federal healthcare providers, including respiratory, gastrointestinal, and bloodstream infection testing panels. As a civilian agency procurement, this contract strengthens diagnostic capacity within the VA's healthcare delivery network while leveraging Biofire's proven molecular diagnostic expertise and established supply relationships with federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | $99.8k | 10/24/25 | |
| P00003 | Funding Only Action | ($267k) | 1/5/23 | |
| P00002 | Supplemental Agreement for work within scope | $199.5k | 7/28/22 | |
| P00001 | Supplemental Agreement for work within scope | $247.4k | 7/12/22 | |
| Not listed | Not listed | $1.2m | 10/1/21 |